TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 1 | -1 | 1 | 24 | 78 | 0 | 21 |
| P | %wins | 100 | 0 | 100 | 100 | 100 | 80 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/18/24 16:06 | 3/14/24 | ALXO | Alx Oncology Holdings Inc | DE | Health | Drug | Pharmaceutical Preparations | Lettmann Jason | CA | DO | CEO | P | 50 | 11.31 | 0 | 4 | 3 | 172 | D | ||||||||||||||
7/21/20 21:31 | 7/21/20 | ALXO | Alx Oncology Holdings Inc | DE | Health | Drug | Pharmaceutical Preparations | Lettmann Jason | CA | DT | P.d | 7,600 | 19.00 | 0 | 400 | 227 | M | ||||||||||||||||
10/31/16 16:51 | 10/31/16 | RARX | Ra Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Lettmann Jason | CA | D | P.d | 5,121 | 13.00 | 21 | 394 | 11 | 4,067 | I | 1 | -1 | 1 | 24 | 78 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |